Valever 500 Tablet CR
Product Info
Prescription required | Yes |
Marketer | Heveren Healthcare Pvt Ltd |
Active Ingredient | Sodium Valproate (333mg) + Valproic Acid (145mg) |
Storage | Store below 30°C |
Habit Forming | No |
Therapeutic Class | NEURO CNS |
User Rating | 4.2 |
User Reviews | 533 |
FAQ
Valever 500 Tablet CR Reviews
Valever 500 should be taken with food. Your doctor will decide the correct dose for you. This may increase gradually until your condition is stable. This medicine may take several weeks to work but it is important to take it regularly to get the benefit. Do not stop taking it, even if you feel fine unless your doctor advises you to. You may have more seizures, or your bipolar disorder may get worse.
The most common side effects of this medicine are nausea and tremor. In some people, it may also cause other side effetcs like vomiting, headache, liver injury, and upper abdominal pain. Most side effects wear off, but if they bother you or do not go away, tell your doctor. There may be ways of preventing or reducing these effects.
Before taking this medicine, tell your doctor if you have kidney or liver problems, meningitis or depression or suicidal thoughts. Also let your doctor know about all other medications you are using as some may affect, or be affected by, this medicine, including contraceptive pills. If you are pregnant or breastfeeding, Valever 500 can be taken if it is clearly needed but the dose may be adjusted. You should avoid driving or riding a bicycle if this medicine makes you drowsy or dizzy. You may need frequent blood tests to check how you are responding to this medicine.
You should avoid alcohol while taking Valever 500, as it may worsen certain side effects. This medicine can also lead to weight gain, eat a healthy balanced diet, avoid snacking with high-calorie food, and exercise regularly. Inform your doctor if you develop any unusual changes in mood or behavior, new or worsening depression, or suicidal thoughts or behavior.
How Valever 500 Tablet CR Works
How to Use Valever 500 Tablet CR
Benefits of Valever 500 Tablet CR
- In Epilepsy: Valever 500 slows down electrical signals in the brain which cause seizures (fits). It can also help reduce symptoms such as confusion, uncontrollable jerking movements, loss of awareness, and fear or anxiety. The medicine can allow you to do some activities that you would otherwise be forbidden or scared to do (such as swimming and driving). It can take a few weeks for this medicine to work (because the dose has to be increased slowly) and during this time you may still have seizures. Do not stop using this medicine even if you feel well, until your doctor advises you to. Missing doses may trigger a seizure.
Uses of Valever 500 Tablet CR
- Epilepsy
Valever 500 Tablet CR Side Effects
Safety Tips
Quick Tips
- Monitor your weight during the treatment as Valever 500 can cause weight gain.
- Your doctor may monitor Valever 500 level, blood counts and liver function regularly throughout your treatment. Inform your doctor if you develop fever, stomach pain, nausea or yellowing of your eyes or skin.
- Do not stop taking the medication suddenly without talking to your doctor as it may increase the seizure frequency.
- Do not take Valever 500 if you are pregnant or planning to conceive or breastfeeding.
- You have been prescribed Valever 500 for treatment and prevention of seizures.
- Do not drive or do anything that requires mental focus until you know how Valever 500 affects you.
- Avoid consuming alcohol when taking Valever 500, as it may cause excessive sleepiness or drowsiness.
- Take it at the same time every day to maintain consistent levels in your body.
References
- Drugs.com. Sodium Valporate.
- Drugs.com. Valporic acid.
- Linde M, Mulleners WM, Chronicle EP, et al. Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev. 2013;(6):CD010611.
- Sodium Valproate and Valproic Acid [Package Information]. Gangtok, Sikkim: TORRENT PHARMACEUTICALS LTD.; 2022.